Regulation of Cyr61/CCN1 expression by hypoxia through cooperation of c-Jun/AP-1 and HIF-1α in retinal vascular endothelial cells

Experimental Eye Research

Volumn 91, Issue 6, 2010, Pages 825-836

  You, Jian Jang ^a,c   Yang, Chung May ^b   Chen, Muh Shy ^b   Yang, Chang Hao ^b  

^a KEELUNG HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHING KUO INSTITUTE OF MANAGEMENT AND HEALTH   (Taiwan)

Author keywords

Activator protein 1; Cysteine rich 61; Hypoxia; Hypoxia inducible factor 1 ; Proliferative diabetic retinopathy

Indexed keywords

CYSTEINE RICH PROTEIN 61; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL HYPOXIA; CONTROLLED STUDY; ENDOTHELIUM CELL; GEL MOBILITY SHIFT ASSAY; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RETINA BLOOD VESSEL; RETINA CELL; TRANSCRIPTION REGULATION;

ANIMALS; ANOXIA; BLOTTING, WESTERN; CELLS, CULTURED; CYSTEINE-RICH PROTEIN 61; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENES, REPORTER; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MACACA; MUTAGENESIS, SITE-DIRECTED; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-JUN; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1;

EID: 78649484217     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2010.10.006     Document Type: Article

References (55)

1. Aiello L.P., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., Ferris F.L., Klein R. Diabetic retinopathy. Diabetes Care 1998, 21:143-156.
2. Alfranca A., Gutierrez M.D., Vara A., Aragones J., Vidal F., Landazuri M.O. c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription. Mol. Cell. Biol. 2002, 22:12-22.
3. Athanasopoulos A.N., Schneider D., Keiper T., Alt V., Pendurthi U.R., Liegibel U.M., Sommer U., Nawroth P.P., Kasperk C., Chavakis T. Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing. J. Biol. Chem. 2007, 282:26746-26753.
4. Ausserer W.A., Bourrat-Floeck B., Green C.J., Laderoute K.R., Sutherland R.M. Regulation of c-jun expression during hypoxic and low-glucose stress. Mol. Cell. Biol. 1994, 14:5032-5042.
5. Babic A.M., Kireeva M.L., Kolesnikova T.V., Lau L.F. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6355-6360.
6. Bandyopadhyay R.S., Phelan M., Faller D.V. Hypoxia induces AP-1-regulated genes and AP-1 transcription factor binding in human endothelial and other cell types. Biochim. Biophys. Acta 1995, 1264:72-78.
7. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13681-13686.
8. Brigstock D.R. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis 2002, 5:153-165.
9. Cummins E.P., Taylor C.T. Hypoxia-responsive transcription factors. Pflugers Arch. 2005, 450:363-371.
10. Damert A., Ikeda E., Risau W. Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem. J. 1997, 327(Pt 2):419-423.
11. Desbaillets I., Diserens A.C., Tribolet N., Hamou M.F., Van Meir E.G. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J. Exp. Med. 1997, 186:1201-1212.
12. Fong D.S., Aiello L., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., Ferris F.L., Klein R. Diabetic retinopathy. Diabetes Care 2003, 26(Suppl. 1):S99-S102.
13. Gerald D., Berra E., Frapart Y.M., Chan D.A., Giaccia A.J., Mansuy D., Pouyssegur J., Yaniv M., Mechta-Grigoriou F. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 2004, 118:781-794.
14. Grammas P., Riden M. Retinal endothelial cells are more susceptible to oxidative stress and increased permeability than brain-derived endothelial cells. Microvasc. Res. 2003, 65:18-23.
15. Grzeszkiewicz T.M., Lindner V., Chen N., Lam S.C., Lau L.F. The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans. Endocrinology 2002, 143:1441-1450.
16. Hai T., Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:3720-3724.
17. Jedsadayanmata A., Chen C.C., Kireeva M.L., Lau L.F., Lam S.C. Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). J. Biol. Chem. 1999, 274:24321-24327.
18. Jin N., Hatton N., Swartz D.R., Xia X., Harrington M.A., Larsen S.H., Rhoades R.A. Hypoxia activates jun-N-terminal kinase, extracellular signal-regulated protein kinase, and p38 kinase in pulmonary arteries. Am. J. Respir. Cell Mol. Biol. 2000, 23:593-601.
19. Karin M., Shaulian E. AP-1: linking hydrogen peroxide and oxidative stress to the control of cell proliferation and death. IUBMB Life 2001, 52:17-24.
20. Kireeva M.L., Lam S.C., Lau L.F. Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin alphavbeta3. J. Biol. Chem. 1998, 273:3090-3096.
21. Kuiper E.J., de Smet M.D., van Meurs J.C., Tan H.S., Tanck M.W., Oliver N., van Nieuwenhoven F.A., Goldschmeding R., Schlingemann R.O. Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye. Arch. Ophthalmol. 2006, 124:1457-1462.
22. Kuiper E.J., Hughes J.M., Van Geest R.J., Vogels I.M., Goldschmeding R., Van Noorden C.J., Schlingemann R.O., Klaassen I. Effect of VEGF-A on expression of profibrotic growth factor and extracellular matrix genes in the retina. Invest. Ophthalmol. Vis. Sci. 2007, 48:4267-4276.
23. Kunz M., Hartmann A., Flory E., Toksoy A., Koczan D., Thiesen H.J., Mukaida N., Neumann M., Rapp U.R., Brocker E.B., Gillitzer R. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am. J. Pathol. 1999, 155:753-763.
24. Kunz M., Ibrahim S.M. Molecular responses to hypoxia in tumor cells. Mol. Cancer 2003, 2(23).
25. Kunz M., Moeller S., Koczan D., Lorenz P., Wenger R.H., Glocker M.O., Thiesen H.J., Gross G., Ibrahim S.M. Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells. J. Biol. Chem. 2003, 278:45651-45660.
26. Kuwabara K., Ogawa S., Matsumoto M., Koga S., Clauss M., Pinsky D.J., Lyn P., Leavy J., Witte L., Joseph-Silverstein J., et al. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:4606-4610.
27. Laderoute K.R. The interaction between HIF-1 and AP-1 transcription factors in response to low oxygen. Semin. Cell Dev. Biol. 2005, 16:502-513.
28. Laderoute K.R., Webster K.A. Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes. Circ. Res. 1997, 80:336-344.
29. Lin M.T., Kuo I.H., Chang C.C., Chu C.Y., Chen H.Y., Lin B.R., Sureshbabu M., Shih H.J., Kuo M.L. Involvement of hypoxia-inducing factor-1alpha-dependent plasminogen activator inhibitor-1 up-regulation in Cyr61/CCN1-induced gastric cancer cell invasion. J. Biol. Chem. 2008, 283:15807-15815.
30. Liu H., Yang R., Tinner B., Choudhry A., Schutze N., Chaqour B. Cysteine-rich protein 61 and connective tissue growth factor induce deadhesion and anoikis of retinal pericytes. Endocrinology 2008, 149:1666-1677.
31. Lukiw W.J., Ottlecz A., Lambrou G., Grueninger M., Finley J., Thompson H.W., Bazan N.G. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest. Ophthalmol. Vis. Sci. 2003, 44:4163-4170.
32. Meyuhas R., Pikarsky E., Tavor E., Klar A., Abramovitch R., Hochman J., Lago T.G., Honigman A. A key role for cyclic AMP-responsive element binding protein in hypoxia-mediated activation of the angiogenesis factor CCN1 (CYR61) in Tumor cells. Mol. Cancer Res. 2008, 6:1397-1409.
33. Michiels C., Minet E., Michel G., Mottet D., Piret J.P., Raes M. HIF-1 and AP-1 cooperate to increase gene expression in hypoxia: role of MAP kinases. IUBMB Life 2001, 52:49-53.
34. Millhorn D.E., Raymond R., Conforti L., Zhu W., Beitner-Johnson D., Filisko T., Genter M.B., Kobayashi S., Peng M. Regulation of gene expression for tyrosine hydroxylase in oxygen sensitive cells by hypoxia. Kidney Int. 1997, 51:527-535.
35. Minet E., Michel G., Mottet D., Piret J.P., Barbieux A., Raes M., Michiels C. c-JUN gene induction and AP-1 activity is regulated by a JNK-dependent pathway in hypoxic HepG2 cells. Exp. Cell Res. 2001, 265:114-124.
36. Mizukami Y., Yoshioka K., Morimoto S., Yoshida K. A novel mechanism of JNK1 activation. Nuclear translocation and activation of JNK1 during ischemia and reperfusion. J. Biol. Chem. 1997, 272:16657-16662.
37. 2-responsive sequences on the tyrosine hydroxylase gene. J. Biol. Chem. 1995, 270:23774-23779.
38. Nyengaard J.R., Ido Y., Kilo C., Williamson J.R. Interactions between hyperglycemia and hypoxia: implications for diabetic retinopathy. Diabetes 2004, 53:2931-2938.
39. O'Brien T.P., Yang G.P., Sanders L., Lau L.F. Expression of cyr61, a growth factor-inducible immediate-early gene. Mol. Cell. Biol. 1990, 10:3569-3577.
40. Salceda S., Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 1997, 272:22642-22647.
41. Salnikow K., Kluz T., Costa M., Piquemal D., Demidenko Z.N., Xie K., Blagosklonny M.V. The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia. Mol. Cell. Biol. 2002, 22:1734-1741.
42. Schutze N., Rucker N., Muller J., Adamski J., Jakob F. 5' flanking sequence of the human immediate early responsive gene ccn1 (cyr61) and mapping of polymorphic CA repeat sequence motifs in the human ccn1 (cyr61) locus. Mol. Pathol. 2001, 54:170-175.
43. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 2002, 4:E131-E136.
44. Shi Q., Le X., Abbruzzese J.L., Wang B., Mujaida N., Matsushima K., Huang S., Xiong Q., Xie K. Cooperation between transcription factor AP-1 and NF-kappaB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia. J. Interferon Cytokine Res. 1999, 19:1363-1371.
45. Shih S.C., Claffey K.P. Role of AP-1 and HIF-1 transcription factors in TGF-beta activation of VEGF expression. Growth Factors 2001, 19:19-34.
46. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
47. Webster K.A., Discher D.J., Bishopric N.H. Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxic cardiac myocytes. J. Biol. Chem. 1993, 268:16852-16858.
48. Wisdom R. AP-1: one switch for many signals. Exp. Cell Res. 1999, 253:180-185.
49. Woo K.J., Lee T.J., Park J.W., Kwon T.K. Desferrioxamine, an iron chelator, enhances HIF-1alpha accumulation via cyclooxygenase-2 signaling pathway. Biochem. Biophys. Res. Commun. 2006, 343:8-14.
50. Yamashita K., Discher D.J., Hu J., Bishopric N.H., Webster K.A. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J. Biol. Chem. 2001, 276:12645-12653.
51. You J.J., Yang C.H., Chen M.S., Yang C.M. Cysteine-rich 61, a member of the CCN family, is involved in the pathogenesis of proliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci 2009.
52. You J.J., Yang C.H., Huang J.S., Chen M.S., Yang C.M. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis. Invest. Ophthalmol. Vis. Sci. 2007, 48:5290-5298.
53. Yu Y., Gao Y., Wang H., Huang L., Qin J., Guo R., Song M., Yu S., Chen J., Cui B., Gao P. The matrix protein CCN1 (CYR61) promotes proliferation, migration and tube formation of endothelial progenitor cells. Exp. Cell Res. 2008, 314:3198-3208.
54. Zhou D., Herrick D.J., Rosenbloom J., Chaqour B. Cyr61 mediates the expression of VEGF, alphav-integrin, and alpha-actin genes through cytoskeletally based mechanotransduction mechanisms in bladder smooth muscle cells. J. Appl. Physiol. 2005, 98:2344-2354.
55. Zhou W., Negash S., Liu J., Raj J.U. Modulation of pulmonary vascular smooth muscle cell phenotype in hypoxia: role of cGMP-dependent protein kinase and myocardin. Am. J. Physiol. Lung Cell Mol. Physiol. 2009, 296:L780-L789.